v3.26.1
Note 16 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Feb. 28, 2026
Nov. 30, 2025
Aug. 31, 2025
Feb. 28, 2025
Nov. 30, 2024
Aug. 31, 2024
Feb. 28, 2026
Feb. 28, 2025
Net (loss) income $ (25,233)     $ (793,534)     $ (67,229) $ (913,461)
Net comprehensive (loss) income (29,920) $ (39,045) $ 1,325 (798,923) $ (94,241) $ (30,492) (67,640) (923,656)
Comprehensive (loss) income attributable to NCI $ 1,557     $ (4,509)     5,320 (277)
Subsidiaries [Member]                
Revenue             46,973 53,608
Total expenses             37,080 59,625
Net (loss) income             9,893 (6,017)
Other comprehensive (loss) income             (494) (1,438)
Net comprehensive (loss) income             9,399 (7,455)
Comprehensive (loss) income attributable to NCI             4,517 (277)
Net comprehensive (loss) income attributable to NCI             4,517 (277)
Enroot [Member]                
Revenue             27  
Total expenses             37  
Net (loss) income             (10)  
Other comprehensive (loss) income             0  
Net comprehensive (loss) income             $ (10)  
Non-controlling interest % 25.00%           25.00%  
Comprehensive (loss) income attributable to NCI             $ (3)  
Net comprehensive (loss) income attributable to NCI             (3)  
Aphria Diamond [Member]                
Revenue             46,946 53,608
Total expenses             37,696 39,557
Net (loss) income             9,250 14,051
Other comprehensive (loss) income             (72) (1,568)
Net comprehensive (loss) income             $ 9,178 $ 12,483
Non-controlling interest % 49.00%     49.00%     49.00% 49.00%
Comprehensive (loss) income attributable to NCI             $ 4,497 $ 6,117
Net comprehensive (loss) income attributable to NCI             4,497 6,117
ColCanna S.A.S. [Member]                
Revenue             0 0
Total expenses             (653) 62
Net (loss) income             653 (62)
Other comprehensive (loss) income             (422) 127
Net comprehensive (loss) income             $ 231 $ 65
Non-controlling interest % 10.00%     10.00%     10.00% 10.00%
Comprehensive (loss) income attributable to NCI             $ 23 $ 7
Net comprehensive (loss) income attributable to NCI             $ 23 7
Superhero Acquisition LP [Member]                
Revenue               0
Total expenses               20,000
Net (loss) income               (20,000)
Other comprehensive (loss) income               0
Net comprehensive (loss) income               $ (20,000)
Non-controlling interest %       32.00%       32.00%
Comprehensive (loss) income attributable to NCI               $ (6,400)
Net comprehensive (loss) income attributable to NCI               (6,400)
CC Pharma Nordic ApS [Member]                
Revenue               0
Total expenses               6
Net (loss) income               (6)
Other comprehensive (loss) income               3
Net comprehensive (loss) income               $ (3)
Non-controlling interest %       25.00%       25.00%
Comprehensive (loss) income attributable to NCI               $ (1)
Net comprehensive (loss) income attributable to NCI               $ (1)